Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal Scintigraphy in Adults: An Update.

Seminars in nuclear medicine·2025
Same author

PET in myeloma redefined: a comparative imaging study with FDG and fluorocholine PET/CT.

European journal of nuclear medicine and molecular imaging·2025
Same author

Multimodal imaging analysis of autosomal recessive Parkinson's disease.

Annals of nuclear medicine·2025
Same author

Comparing laboratory toxicity of selective intra-arterial radionuclide therapy for primary and metastatic liver tumors: resin versus glass microspheres.

Annals of nuclear medicine·2025
Same author

Ictal Coprolalia: Three Cases with Nondominat Frontal Lobe Involvement and Review of the Literature.

Clinical EEG and neuroscience·2024
Same author

Pediatric nuclear medicine: continuing the evolution.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2024

Related Experiment Video

Updated: Jul 1, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

528

Current approach to pediatric differentiated thyroid cancer.

Pinar Ozgen Kiratli1, Bilge Volkan-Salanci2

  • 1Department of Nuclear Medicine, Hacettepe University Medical Center, Ankara, Türkiye.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of
|March 6, 2024
PubMed
Summary

Differentiated thyroid cancer (DTC) in children is rare and differs from adult cases. A multidisciplinary approach improves outcomes and quality of life for pediatric DTC patients.

More Related Videos

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.7K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K

Related Experiment Videos

Last Updated: Jul 1, 2025

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

528
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
05:12

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy

Published on: May 12, 2023

3.7K
Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

1.6K

Area of Science:

  • Pediatric Oncology
  • Endocrinology
  • Cancer Research

Background:

  • Differentiated thyroid cancer (DTC) in pediatric populations presents unique clinical and biological characteristics distinct from adults.
  • Current management guidelines are largely extrapolated from adult data, with limited specific research on children and adolescents.
  • Unsettled issues persist regarding optimal patient management and therapeutic strategies for pediatric DTC.

Purpose of the Study:

  • To review existing literature on the management of differentiated thyroid cancer in pediatric patients.
  • To provide an overview of current approaches to pediatric DTC.
  • To highlight the need for age-specific considerations in DTC treatment.

Main Methods:

  • Literature review of studies focusing on pediatric differentiated thyroid cancer.
  • Analysis of clinical presentation, biological behavior, and treatment outcomes in children and adolescents.
  • Synthesis of data from small cohorts and heterogeneous retrospective studies.

Main Results:

  • Pediatric DTC, while aggressive in nature, demonstrates excellent overall survival rates.
  • Standard treatment involves thyroidectomy, lymph node dissection for metastases, and potentially Iodine-131 radiotherapy.
  • Disease characteristics and management vary significantly across different pediatric age groups.

Conclusions:

  • A comprehensive, multidisciplinary approach is crucial for managing pediatric DTC.
  • This integrated strategy can lead to reduced treatment side effects.
  • Optimizing care through a multidisciplinary team enhances the quality of life for young DTC patients.